CIBC Reaffirms Outperformer Rating for Nutrien (NYSE:NTR)

Nutrien (NYSE:NTRGet Free Report)‘s stock had its “outperformer” rating reaffirmed by analysts at CIBC in a research note issued to investors on Tuesday,Benzinga reports. They presently have a $55.00 target price on the stock, down from their prior target price of $60.00. CIBC’s target price suggests a potential upside of 14.87% from the company’s current price.

Several other equities research analysts also recently issued reports on the company. UBS Group downgraded Nutrien from a “buy” rating to a “neutral” rating and cut their price target for the company from $66.00 to $51.00 in a report on Thursday, October 10th. TD Securities decreased their price target on shares of Nutrien from $63.00 to $61.00 and set a “buy” rating on the stock in a research note on Tuesday, November 12th. Wells Fargo & Company downgraded shares of Nutrien from an “overweight” rating to an “equal weight” rating and cut their price objective for the stock from $62.00 to $50.00 in a research report on Tuesday, September 24th. Raymond James raised Nutrien from a “market perform” rating to an “outperform” rating and upped their target price for the company from $58.00 to $60.00 in a research report on Tuesday, December 3rd. Finally, Barclays reduced their price target on Nutrien from $68.00 to $55.00 and set an “overweight” rating for the company in a research note on Friday, August 16th. Three equities research analysts have rated the stock with a sell rating, four have issued a hold rating and ten have assigned a buy rating to the company’s stock. According to MarketBeat.com, Nutrien has an average rating of “Hold” and an average target price of $58.89.

Check Out Our Latest Research Report on NTR

Nutrien Trading Down 1.4 %

NYSE NTR opened at $47.88 on Tuesday. Nutrien has a 12 month low of $44.65 and a 12 month high of $60.87. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. The stock has a 50 day moving average of $47.96 and a 200-day moving average of $49.18. The company has a market cap of $23.65 billion, a PE ratio of 32.13, a PEG ratio of 1.69 and a beta of 0.80.

Nutrien (NYSE:NTRGet Free Report) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 earnings per share for the quarter, missing the consensus estimate of $0.43 by ($0.04). The firm had revenue of $5.35 billion for the quarter, compared to analyst estimates of $5.26 billion. Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The firm’s revenue for the quarter was down 5.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.35 earnings per share. On average, equities research analysts anticipate that Nutrien will post 3.54 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Lester Murray Antman dba SimplyRich increased its position in Nutrien by 2.3% during the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 9,069 shares of the company’s stock worth $461,000 after purchasing an additional 202 shares in the last quarter. FFT Wealth Management LLC grew its position in Nutrien by 0.8% during the 2nd quarter. FFT Wealth Management LLC now owns 29,220 shares of the company’s stock worth $1,488,000 after acquiring an additional 220 shares during the last quarter. MONECO Advisors LLC increased its holdings in Nutrien by 2.4% in the 2nd quarter. MONECO Advisors LLC now owns 9,791 shares of the company’s stock worth $498,000 after purchasing an additional 233 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its position in Nutrien by 6.5% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 4,309 shares of the company’s stock valued at $207,000 after purchasing an additional 263 shares during the last quarter. Finally, Royal London Asset Management Ltd. grew its holdings in shares of Nutrien by 1.1% during the second quarter. Royal London Asset Management Ltd. now owns 23,995 shares of the company’s stock worth $1,222,000 after purchasing an additional 265 shares during the last quarter. Institutional investors and hedge funds own 63.10% of the company’s stock.

About Nutrien

(Get Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Articles

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.